SCHEMBL4428909

SCHEMBL4428909

CC(C)(C)C1CC(C(=O)O)(S(=O)(=O)N2CCC(=O)CC2)CCN1Cc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
GRM6 O15303 1/20 0.35
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
SIGMAR1 Q99720 2/20 0.33
MMP1 P03956 1/20 0.33
MMP9 P14780 1/20 0.33
MMP13 P45452 1/20 0.33
ADAM17 P78536 1/20 0.33
HSD11B1 P28845 2/20 0.32
TSHR P16473 2/20 0.32
MAPT P10636 1/20 0.32
PDK1 Q15118 1/20 0.32
PDK2 Q15119 1/20 0.32
PDK3 Q15120 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222005 0.78 CYP2D6 (0.49) CYP2D6CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL12971547 0.73 CYP2D6 (0.50) CYP2D6CYP3A4CYP2C9CYP2C19ALDH1A1
Tert-Butyl Formate SCHEMBL27628652 0.71 CYP2D6 (0.32) CYP2D6CYP3A4CYP2C19ALDH1A1MEN1
SCHEMBL14034000 0.70 PARP1 (0.39) CYP2C19ALDH1A1SIGMAR1PDK1PDK2
SCHEMBL6272775 0.70
SCHEMBL6973071 0.66 DRD2 (0.38) CYP2D6CYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL14034171 0.66 NPY1R (0.39) ALDH1A1SIGMAR1TSHROPRL1HTT
SCHEMBL6963483 0.66
SCHEMBL5808971 0.65 OPRM1 (0.39) SIGMAR1
SCHEMBL24926340 0.62 ACHE (0.45) CYP2D6CYP3A4CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009158646-A1 THERAPEUTIC COMPUNDS AND RELATED METHODS OF USE ELIXIR PHARMACEUTICALS, INC. (US) 2009-12-30 WO disclosed